InsidersTradesSigma
RenovoRx, Inc.: management transactions · United States · SEC (Form 4)
SEC:renovorx-inc-1e6856US·SEC (Form 4)Mcap 36M€Healthcare
Browse the full insider trade history of RenovoRx, Inc., a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, RenovoRx, Inc. has recorded 3 reports. Market capitalisation: €36.1m. The latest transaction was disclosed on 17 June 2022 (C). Among the most active insiders: Agah Ramtin. The full history is accessible without an account.
3
Insider Decl.
0
Thresholds
€10,658
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.80 €
Analyst consensus
4 analystsStrong buy
3.00 €Target 6.91 €(+762%)13.50 €
Income statement
Revenue1.1 M€
Gross profit796 k€71% margin
Net income−11.2 M€-994.5% margin
Valuation
PER (forward)-6.2x
P/Book3.2x
Balance sheet & cash
Market cap36.1 M€
Total debt212 k€
Free Cash Flow−11.0 M€
Debt / Equity1%
Profitability & ownership
ROE-100.5%
ROA-51.6%
% insiders3.8%
% institutions19.0%
Last declaration on 17 June 2022
Declarations3 total
Executives●C16SEC
1,295 shares
Common Stock
SEC:0001493152-22-017155:0·
Executives●Don16SEC
0975,000 shares0
Common Stock
SEC:0001493152-22-016226:0·
Executives▲Purchase43SEC
€10,6585,500 shares@ €1.93780.030% mcap100.0% of flow
Common Stock
SEC:0001209191-22-031236:0·
Ideal exit: 13 Feb 2023 (T+270)
3 of 3 declarations